相关产品推荐更多 >

Mouse Exendin 4 ELISA Kit/Mouse Exendin 4 ELISA Kit
询价
EZElisa™脂肪酸结合蛋白8,髓鞘(FABP8)试剂盒-EZElisa™ Fatty Acid Binding Protein 8, Myelin (FABP8) Kit
询价
Cat Tissue Specific Transplantation Antigen ELISA Kit/Cat Tissue Specific Transplantation Antigen ELISA Kit
询价
Cavy Glycogen Synthase Kinase ELISA Kit/Cavy Glycogen Synthase Kinase ELISA Kit
询价
Bovine Cytokeratin 17 ELISA Kit/Bovine Cytokeratin 17 ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ Interferon alpha-8 (IFNA8) Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™ Interferon alpha-8(IFNA 8)套件,EZElisa™ Interferon alpha-8 (IFNA8) Kit, Interferon alpha-8(IFNA 8)套件, Interferon alpha-8 (IFNA8) Kit
产品名称:EZElisa™ Interferon alpha-14(IFNA 14)套件-EZElisa™ Interferon alpha-8 (IFNA8) Kit
产品货号:A-QEK07320-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of EZElisa™ Interferon alpha - 8 (IFNA8) in serum and plasma, tissue homogenates and other biological fluids.
种属:Human
检测方法:比色法
检测范围:7.813 - 500 pg/ml

该EZElisa™ Interferon alpha-8(IFNA 8)套件ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™ Interferon alpha-14(IFNA 14)套件-EZElisa™ Interferon alpha-8 (IFNA8) Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Measuring Interferon Alpha and Other Cytokines in SLE
The progression of disease in patients with systemic lupus erythematosus (SLE) is affected by production, accumulation, and actions of cytokines. Type I interferon (IFN), specifically IFN-α, is recognized as a central mediator of disease
motifs located prevalently in the 3′ untranslated regions of target messenger RNAs (mRNA). Interferon-alpha-2a (IFNα) induces a large set of protein coding genes mediating antiproliferative and antiviral responses. Here we use a global microarray-based
Interferon Alpha, GM-CSF-Activated T Cells, and IL-6 in Renal Cell Carcinoma
an optimal beneficial way of administering IL-2. In addition, investigation also led to other immunotherapy agents such as interferon and cellular therapy.
技术资料暂无技术资料 索取技术资料





